학술논문
937P Survival outcomes in phase I trial combining VCN-01 and durvalumab (MEDI4736) in subjects with recurrent/metastatic head and neck squamous cell carcinoma refractory to previous immunotherapy treatment
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S589-S590
Subject
Language
ISSN
0923-7534